Description of the medicine: Diuciphonum

Diuciphonum. Para-para- (2, 4-dioxo-6-methylpyrimidinyl-5-sulfonamino) -diphenylsulfone.

White or white with cream-colored crystalline powder. Derivative of diaminodiphenylsulfone with two methyluracil residues.

The compound was synthesized from the calculation of an active antileprosed drug with better tolerability than diaminodiphenylsulfone, and with a stimulating effect on metabolic processes in the body.

It is established that the diucifone has a pronounced immunomodulating activity.

A diucifon is used to treat leprosy patients, as well as complex therapy of a number of diseases accompanied by an immunodeficient state of the body, including dermatoses (psoriasis, scleroderma, etc.), rheumatoid arthritis, tuberculosis, chronic nonspecific pulmonary diseases, etc.

Assign diuzifon inside 0.1 g 3 - 4 times a day or injected intramuscularly 4 ml 5% solution (0.2 g) 1 time per day.

When leprosy take a long time in conjunction with other means. With dermatoses and other diseases, treatment is usually performed with 5 - day cycles with a one - day break. The duration of application depends on the nature and course of the disease, the efficacy and tolerability of the drug.

With a decrease in the immunological reactivity of the body, patients with pulmonary pathology are prescribed 2 courses of intramuscular injections for 3 injections every other day with a 2-day break between courses - a total of 6 injections.

Product: powder.